Skip to content

Home-Based Walking for Thinking Skills in Persons With TBI

Safety and Feasibility of Remote Walking Exercise for Cognitive Improvement in Persons With TBI

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07733284
Acronym
SWEAT-TBI
Enrollment
40
Registered
2026-07-29
Start date
2026-04-15
Completion date
2026-12-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury (TBI) Patients

Keywords

walking, thinking, fitbit, exercise

Brief summary

The purpose of this research study is to investigate the effects of a home-based 3-month long walking exercise program on cognitive (thinking) performance in persons with TBI. As a participant, you will complete this 3-month exercise program now or after a 3-month wait period.

Detailed description

This study involves no in-person visits to Kessler Foundation and takes place at home. The first study activity will last about 1 hour in total and will involve using videoconferencing software (Zoom) to take tests of thinking (e.g., matching shapes and number, learning a list of words). You will then complete several brief questionnaires about everyday activities and TBI symptoms over the computer. You will then be randomly picked (like the flip of a coin) by a computer to participate in one of two groups. You will have a 50/50 chance of being placed in either group. One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends. The other group will stick to a regular routine during this 3-month period (i.e., wait-list group). At the end of the 3-month exercise program, you will repeat the thinking tests and questionnaires. The wait-list group will be given the exercise prescription after this last Zoom session.

Interventions

BEHAVIORALWalking

One group will complete 3-months of walking exercise at home. The exercise program is based on activity guidelines for people with TBI and will be monitored by a trained exercise leader. You will be asked to walk 3 times per week. The first two weeks will require you to walk for 10 minutes at a time, and that duration will increase throughout the 3-months. You will have a dedicated trainer to help get started, answer questions, and support you throughout the programs. You will have regular meetings with this trainer by video conference (Zoom). You will be sent a FitBit to wear on your wrist while exercising to track your steps, and that you will be allowed to keep when the study ends.

Sponsors

Kessler Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Definitive TBI diagnosis at least 1 year prior, verified by medical records * Self-report problems with thinking skills since the TBI diagnosis (e.g., processing information, learning or remembering, organizing, multitasking) * Between the ages of 18 and 65 * Access to internet and email * Fluent in English * Can walk at a brisk pace without using an assistive device * Not fallen due to mobility issues from their TBI in the past 6 months * Do not currently meet public health guidelines for physical activity * Have problems with thinking performance

Exclusion criteria

* I currently have uncontrolled major depression * I have a history of schizophrenia, bipolar disorder I or II, or substance-abuse disorders * I am regularly taking medications that can affect my thinking, such as antipsychotics or benzodiazepines. Study staff will review my medications to determine if I am taking any that would make me ineligible for this study * I have known/diagnosed cardiovascular disease including uncontrolled hypertension, diabetes, or kidney disease * I am unable to make everyday decisions on my own

Design outcomes

Primary

MeasureTime frameDescription
Adverse EventsThrough study completion, which is 3 months for intervention and 6 months for wait list.Safety will be primarily measured as adverse events, specifically during the remote walking intervention.
AdherenceThrough study completion, which is 3 months for intervention and 6 months for wait list.Adherence is measured as the number of exercise sessions attended compared to the number of total sessions prescribed.
ComplianceThrough study completion, which is 3 months for intervention and 6 months for wait list.Compliance will be measured as the number of exercise sessions completed as prescribed (i.e., intensity and duration).

Secondary

MeasureTime frameDescription
Processing SpeedBaseline and follow-up (12-weeks post-baseline)Neuropsychological assessments will be administered to measure processing speed using the symbol digit modalities test (SDMT).
Learning/MemoryBaseline and follow-up (12-weeks post-baseline)Neuropsychological assessments will be administered to measure processing learning and memory using the California Verbal Learning Test (CVLT).
Executive functionBaseline and follow-up (12-weeks post-baseline)Neuropsychological assessments will be administered to measure executive function using the Delis-Kaplan Executive Function System (DKEFS).

Countries

United States

Contacts

CONTACTCarly Wender, PhD
cwender@kesslerfoundation.org973-324-8388

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026